Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T21:21:03.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:26:57.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting 2023 01 06' has been updated to 'Completed 2024 05 24'. This change indicates that the clinical trial evaluating AB011 Injection in patients with CLDN18.2-positive advanced solid tumors has been completed.
    Difference
    2%
    Check dated 2024-05-25T04:44:14.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of clinical trial records or related documentation. This change likely reflects the addition of a new study or an update in the existing medical and healthcare-related publications.
    Difference
    0.3%
    Check dated 2024-05-22T21:28:05.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:15:35.000Z thumbnail image

Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.